Rapid, cell-free assay for membrane-active forms of amyloid-β

Langmuir

Volumn 31, Issue 14, 2015, Pages 4049-4053

  Bhowmik, Debanjan ^a   Das, Anand Kant ^a   Maiti, Sudipta ^a  

^a TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; CYTOLOGY; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; GLYCOPROTEINS; NEURODEGENERATIVE DISEASES; SPECTROSCOPIC ANALYSIS;

ALZHEIMERS DISEASE; CELL-FREE ASSAYS; DRUG DEVELOPMENT; FLUORESCENCE CORRELATION SPECTROSCOPY; HIGH-THROUGHPUT ASSAYS; MEASUREMENT TIME; MEMBRANE AFFINITY; STRUCTURAL TRANSITIONS;

OLIGOMERS;

AMYLOID BETA PROTEIN; FLUORESCENT DYE; LIPOSOME;

CELL LINE; CELL MEMBRANE; CHEMISTRY; DRUG DEVELOPMENT; METABOLISM; PROCEDURES; PROTEIN MULTIMERIZATION; PROTEIN SECONDARY STRUCTURE; SPECTROFLUOROMETRY; TIME FACTOR;

AMYLOID BETA-PEPTIDES; CELL LINE; CELL MEMBRANE; DRUG DISCOVERY; FLUORESCENT DYES; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; SPECTROMETRY, FLUORESCENCE; TIME FACTORS; UNILAMELLAR LIPOSOMES;

EID: 84927726715     PISSN: 07437463     EISSN: 15205827     Source Type: Journal    
DOI: 10.1021/la502679t     Document Type: Article

References (28)

1. Lambert, M. P.; Barlow, A. K.; Chromy, B. A.; Edwards, C.; Freed, R.; Liosatos, M.; Morgan, T. E.; Rozovsky, I.; Trommer, B.; Viola, K. L.; Wals, P.; Zhang, C.; Finch, C. E.; Krafft, G. A.; Klein, W. L. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 6448-6453
2. Walsh, D. M.; Klyubin, I.; Fadeeva, J. V.; Cullen, W. K.; Anwyl, R.; Wolfe, M. S.; Rowan, M. J.; Selkoe, D. J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo Nature 2002, 416, 535-539
3. Lashuel, H. A.; Hartley, D.; Petre, B. M.; Walz, T.; Lansbury, P. T., Jr. Neurodegenerative disease: amyloid pores from pathogenic mutations Nature 2002, 418, 291
4. Dubnovitsky, A.; Sandberg, A.; Rahman, M. M.; Benilova, I.; Lendel, C.; Hard, T. Amyloid-beta Protofibrils: Size, Morphology and Synaptotoxicity of an Engineered Mimic PLoS One 2013, 8
5. Shankar, G. M.; Bloodgood, B. L.; Townsend, M.; Walsh, D. M.; Selkoe, D. J.; Sabatini, B. L. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway J. Neurosci. 2007, 27, 2866-2875
6. Benilova, I.; Karran, E.; De Strooper, B. The toxic Abeta oligomer and Alzheimers disease: an emperor in need of clothes Nat. Neurosci 2012, 15, 349-357
7. Nag, S.; Sarkar, B.; Bandyopadhyay, A.; Sahoo, B.; Sreenivasan, V. K.; Kombrabail, M.; Muralidharan, C.; Maiti, S. Nature of the amyloid-beta monomer and the monomer-oligomer equilibrium J. Biol. Chem. 2011, 286, 13827-13833
8. Bhowmik, D.; MacLaughlin, C. M.; Chandrakesan, M.; Ramesh, P.; Venkatramani, R.; Walker, G. C.; Maiti, S. pH changes the aggregation propensity of amyloid-beta without altering the monomer conformation Phys. Chem. Chem. Phys. 2014, 16, 885-889
9. Sarkar, B.; Mithu, V. S.; Chandra, B.; Mandal, A.; Chandrakesan, M.; Bhowmik, D.; Madhu, P. K.; Maiti, S. Significant Structural Differences between Transient Amyloid-beta Oligomers and Less-Toxic Fibrils in Regions Known To Harbor Familial Alzheimers Mutations Angew. Chem. 2014, 53, 6888-6892
10. Sarkar, B.; Das, A. K.; Maiti, S. Thermodynamically stable amyloid-beta monomers have much lower membrane affinity than the small oligomers Front. Physiol. 2013, 4, 84
11. Kakio, A.; Nishimoto, S.; Yanagisawa, K.; Kozutsumi, Y.; Matsuzaki, K. Cholesterol-dependent formation of GM1 ganglioside-bound amyloid beta-protein, an endogenous seed for Alzheimer amyloid J. Biol. Chem. 2001, 276, 24985-24990
12. Wong, P. T.; Schauerte, J. A.; Wisser, K. C.; Ding, H.; Lee, E. L.; Steel, D. G.; Gafni, A. Amyloid-beta Membrane Binding and Permeabilization are Distinct Processes Influenced Separately by Membrane Charge and Fluidity J. Mol. Biol. 2009, 386, 81-96
13. Bag, N.; Ali, A.; Chauhan, V. S.; Wohland, T.; Mishra, A. Membrane destabilization by monomeric hIAPP observed by imaging fluorescence correlation spectroscopy Chem. Commun. 2013, 49, 9155-9157
14. van Rooijen, B. D.; Claessens, M. M.; Subramaniam, V. Membrane interactions of oligomeric alpha-synuclein: potential role in Parkinsons disease Curr. Protein Pept. Sci. 2010, 11, 334-342
15. Decker, H.; Jurgensen, S.; Adrover, M. F.; Brito-Moreira, J.; Bomfim, T. R.; Klein, W. L.; Epstein, A. L.; De Felice, F. G.; Jerusalinsky, D.; Ferreira, S. T. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimers toxic amyloid-beta peptide oligomers J. Neurochem. 2010, 115, 1520-1529
16. Dinamarca, M. C.; Weinstein, D.; Monasterio, O.; Inestrosa, N. C. The synaptic protein neuroligin-1 interacts with the amyloid beta-peptide. Is there a role in Alzheimers disease? Biochemistry 2011, 50, 8127-8137
17. Yanagisawa, K.; Odaka, A.; Suzuki, N.; Ihara, Y. Gm1 Gangloside-Bound Amyloid Beta-Protein (Ab)-a Possible Form of Preamyloid in Alzheimers-Disease Nat. Med. 1995, 1, 1062-1066
18. Hertel, C.; Terzi, E.; Hauser, N.; Jakob-Rotne, R.; Seelig, J.; Kemp, J. A. Inhibition of the electrostatic interaction between beta-amyloid peptide and membranes prevents beta-amyloid-induced toxicity Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 9412-9416
19. Kayed, R.; Sokolov, Y.; Edmonds, B.; McIntire, T. M.; Milton, S. C.; Hall, J. E.; Glabe, C. G. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases J. Biol. Chem. 2004, 279, 46363-46366
20. Fagan, T.; Kagan, B.; Nault, L.; Hwang, W.; Glabe, C.; Lal, R.; Albensi, B.; Teplow, D.; Sokolov, Y. Alzheimer research forum live discussion: Now you see them, now you dont: the amyloid channel hypothesis J. Alzheimers Dis. 2006, 9, 219-224
21. Lin, H.; Bhatia, R.; Lal, R. Amyloid beta protein forms ion channels: implications for Alzheimers disease pathophysiology FASEB J. 2001, 15, 2433-2444
22. Tjernberg, L. O.; Pramanik, A.; Bjorling, S.; Thyberg, P.; Thyberg, J.; Nordstedt, C.; Berndt, K. D.; Terenius, L.; Rigler, R. Amyloid beta-peptide polymerization studied using fluorescence correlation spectroscopy Chem. Biol. 1999, 6, 53-62
23. Sengupta, P.; Garai, K.; Sahoo, B.; Shi, Y.; Callaway, D. J.; Maiti, S. The amyloid beta peptide (Abeta(1-40)) is thermodynamically soluble at physiological concentrations Biochemistry 2003, 42, 10506-10513
24. Sengupta, P.; Balaji, J.; Maiti, S. Measuring diffusion in cell membranes by fluorescence correlation spectroscopy Methods 2002, 27, 374-387
25. Culbertson, C. T.; Jacobson, S. C.; Michael Ramsey, J. Diffusion coefficient measurements in microfluidic devices Talanta 2002, 56, 365-373
26. White, L. A.; Eaton, M. J.; Castro, M. C.; Klose, K. J.; Globus, M. Y.; Shaw, G.; Whittemore, S. R. Distinct regulatory pathways control neurofilament expression and neurotransmitter synthesis in immortalized serotonergic neurons J. Neurosci. 1994, 14, 6744-6753
27. Bokvist, M.; Lindstrom, F.; Watts, A.; Grobner, G. Two types of Alzheimers beta-amyloid (1-40) peptide membrane interactions: Aggregation preventing transmembrane anchoring Versus accelerated surface fibril formation J. Mol. Biol. 2004, 335, 1039-1049
28. Lemkul, J. A.; Bevan, D. R. Lipid composition influences the release of Alzheimers amyloid beta-peptide from membranes Protein Sci. 2011, 20, 1530-1545